Deutsch
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

resveratrol/krebs

Der Link wird in der Zwischenablage gespeichert
Seite 1 von 25 Ergebnisse

Resveratrol selenide preparation for treating cancer

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
CROSS REFERENCE OF RELATED APPLICATION This is a U.S. National Stage under 35 U.S.C 371 of the International Application PCT/CN2014/074242, filed Mar. 28, 2014, which claims priority under 35 U.S.C. 119(a-d) to CN 201410080996.1, filed Mar. 6, 2014. BACKGROUND OF THE PRESENT INVENTION Field of

Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND The recent explosion of obesity, type II diabetes, heart disease, and some cancers in the United States can be largely attributed to two key well-known factors, a lack of a healthy diet and reduced physical activity. Type II diabetes, high blood pressure, and heart disease are components

Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND The recent explosion of obesity, type II diabetes, heart disease, and some cancers in the United States can be largely attributed to two key well-known factors, a lack of a healthy diet and reduced physical activity. Type II diabetes, high blood pressure, and heart disease are components

Medium and device for proliferation of stem cells and treatment of cancer-related stem cell with resveratrol

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
CROSS-REFERENCE TO RELATED APPLICATION This non-provisional application claims priority under 35 U.S.C. .sctn.119(a) on Patent Application No(s). 097132616 filed in Taiwan, R.O.C. on Aug. 27, 2008, the entire contents of which are hereby incorporated by reference. BACKGROUND OF THE INVENTION 1.

Methylated curcumin-resveratrol hybrid molecules for treating cancer

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND OF THE INVENTION In Alzheimer's Disease (AD), the abnormal cleavage of beta amyloid protein precursor from the intracellular membrane often produces a protein A.beta. 1-42 which is incompletely removed by normal clearance processes. It has been reported that soluble beta amyloid oligomers

Lycopene and resveratrol compositions for NK cell activation resulting in anti-neoplastic effect

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
CROSS-REFERENCE TO RELATED APPLICATIONS This United States utility patent application is the .sctn.371 national phase of PCT international patent application no PCT/SG2010/000147, having an international filing date of Apr. 13, 2010, which claims benefit of priority to Singapore Patent Applications

Method for treating gefitinib-resistant non-small-cell lung cancer

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
COPYRIGHT NOTICE A portion of the disclosure of this patent document contains material, which is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure, as it appears in the Patent and Trademark

Boronic acid derivatives of resveratrol for activating deacetylase enzymes

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF THE INVENTION The disclosed invention is generally in the field of small molecule activators of deacetylase enzymes and the treatment of disorders including cancer, cardiovascular disease, inflammation, obesity, diabetes, and neurodegenerative diseases related to the activation of

Compositions comprising a dendrimer-resveratrol complex making and using the same

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND Resveratrol (3,4',5-trihydroxystilbene) (FIG. 1) is a naturally occurring phytoalexin produced by a variety of plants in response to stress. Resveratrol has wide pharmacological applications and is being investigated for the treatment of numerous conditions and/or disorders, such as

Compositions comprising a dendrimer-resveratrol complex and methods for making and using the same

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND Resveratrol (3,4',5-trihydroxystilbene) (FIG. 1) is a naturally occurring phytoalexin produced by a variety of plants in response to stress. Resveratrol has wide pharmacological applications and is being investigated for the treatment of numerous conditions and/or disorders, such as

Resveratrol polymerization compound or pharmaceutically acceptable salt thereof

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
TECHNICAL FIELD The present invention relates to a novel resveratrol polymerization compound or a pharmaceutically acceptable salt thereof and a method for manufacturing the same and relates to foods, pharmaceutical agents, quasi drugs, or cosmetics containing the resveratrol polymerization compound
FIELD OF INVENTION The present invention relates to a polyphenol derivative of the stilbenoid family, namely trans-3,5,4'-trihydroxybibenzyl, also known as dihydro-resveratrol, as a remedial agent. In particular, the present invention presents the usage of dihydro-resveratrol or its
FIELD OF INVENTION The present invention relates to a polyphenol derivative of the stilbenoid family, namely trans-3,5,4'-trihydroxybibenzyl, also known as dihydro-resveratrol, as a remedial agent. In particular, the present invention presents the usage of dihydro-resveratrol as an anti-fibrotic
FIELD OF INVENTION The present invention relates to a polyphenol derivative of the stilbenoid family, namely trans-3,5,4'-trihydroxybibenzyl, also known as dihydro-resveratrol, as a remedial agent. In particular, the present invention presents the usage of dihydro-resveratrol as an anti-fibrotic

Lycopene and resveratrol dietary supplement

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
TECHNICAL FIELD This invention generally relates to dietary supplement. It relates specifically to such dietary supplement compositions comprising lycopene and resveratrol exhibiting certain therapeutic effects, including anti-oxidant, anti-arthritis, suppressing carcinoma growth and mitigating
Treten Sie unserer
Facebook-Seite bei

Die vollständigste Datenbank für Heilkräuter, die von der Wissenschaft unterstützt wird

  • Arbeitet in 55 Sprachen
  • Von der Wissenschaft unterstützte Kräuterkuren
  • Kräutererkennung durch Bild
  • Interaktive GPS-Karte - Kräuter vor Ort markieren (in Kürze)
  • Lesen Sie wissenschaftliche Veröffentlichungen zu Ihrer Suche
  • Suchen Sie nach Heilkräutern nach ihrer Wirkung
  • Organisieren Sie Ihre Interessen und bleiben Sie über Neuigkeiten, klinische Studien und Patente auf dem Laufenden

Geben Sie ein Symptom oder eine Krankheit ein und lesen Sie über Kräuter, die helfen könnten, geben Sie ein Kraut ein und sehen Sie Krankheiten und Symptome, gegen die es angewendet wird.
* Alle Informationen basieren auf veröffentlichten wissenschaftlichen Forschungsergebnissen

Google Play badgeApp Store badge